HFSA 2019 Annual Scientific Meeting (Videos)

Comprehensive Heart Failure Education & Advanced Cardiovascular Care Updates

The 23rd HFSA Annual Scientific Meeting 2019 is one of the premier educational events dedicated exclusively to the science, diagnosis, treatment, and management of heart failure. Organized by the Heart Failure Society of America (HFSA) and held in Philadelphia, Pennsylvania, from September 13–16, 2019, this multidisciplinary conference brought together internationally recognized experts, clinicians, researchers, and healthcare professionals to discuss the latest advances in heart failure care.

The meeting features a robust scientific program designed to address the educational needs of the entire heart failure team, including cardiologists, heart failure specialists, internists, nurses, pharmacists, advanced practice providers, fellows, and trainees. Through plenary sessions, state-of-the-art symposia, invited lectures, expert debates, hands-on workshops, and scientific abstract presentations, participants gain practical insights into contemporary heart failure management and emerging therapies.

The conference focuses on translating cutting-edge research into clinical practice, helping healthcare professionals improve outcomes for patients living with heart failure across the spectrum of care.

Product Details

Course: HFSA Annual Scientific Meeting

Edition: 2019 (23rd Annual Scientific Meeting)

Format: Video Lectures

Event Dates: September 13–16, 2019

Location: Philadelphia, Pennsylvania, USA

Provider: Heart Failure Society of America (HFSA)

Access: On-Demand

Language: English

Course Overview

Heart failure remains one of the leading causes of hospitalization, morbidity, and mortality worldwide. Rapid advances in pharmacologic therapies, mechanical circulatory support, cardiac transplantation, remote monitoring, and multidisciplinary disease management continue to transform patient care.

The HFSA Annual Scientific Meeting provides comprehensive coverage of:

• Heart failure pathophysiology
• Guideline-directed medical therapy (GDMT)
• Advanced heart failure management
• Mechanical circulatory support
• Left ventricular assist devices (LVADs)
• Heart transplantation
• Cardiogenic shock
• Cardio-oncology
• Cardiorenal syndrome
• Heart failure imaging
• Biomarkers
• Emerging therapies
• Clinical trials and research updates

The program emphasizes evidence-based strategies and practical approaches that can be immediately integrated into clinical practice.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Apply current guideline-directed therapies for heart failure management.
• Evaluate patients for advanced heart failure therapies.
• Identify appropriate candidates for mechanical circulatory support and transplantation.
• Incorporate emerging pharmacologic treatments into clinical practice.
• Utilize biomarkers and imaging modalities for diagnosis and monitoring.
• Manage complex heart failure comorbidities.
• Integrate multidisciplinary approaches to optimize patient outcomes.
• Review the latest clinical trials and scientific advances in heart failure care.

Major Topics Covered

❤️ Heart Failure Management

Comprehensive review of:

• HFrEF
• HFpEF
• Acute decompensated heart failure

Clinical Focus

• Evidence-based treatment strategies
• Long-term disease management

💊 Guideline-Directed Medical Therapy (GDMT)

Coverage includes:

• Contemporary pharmacologic therapies
• Medication optimization
• Treatment algorithms

Applications

Improving survival and quality of life.

🫀 Advanced Heart Failure

Discussion of:

• Refractory heart failure
• Referral strategies
• Advanced treatment options

Goal

Early recognition and intervention.

⚙️ Mechanical Circulatory Support

Review of:

• LVAD therapy
• Temporary support devices
• Advanced hemodynamic management

Clinical Importance

Managing end-stage heart failure.

🏥 Heart Transplantation

Coverage includes:

• Candidate selection
• Pre-transplant evaluation
• Post-transplant management

Focus

Optimizing transplant outcomes.

🚨 Cardiogenic Shock

Discussion of:

• Diagnosis
• Hemodynamic assessment
• Mechanical support strategies

Applications

Critical care management.

🔬 Heart Failure Research & Clinical Trials

Review of:

• Landmark studies
• Emerging therapies
• Future directions in heart failure care

Benefit

Staying current with evolving evidence.

🩺 Cardiorenal & Multisystem Disease

Coverage includes:

• Renal dysfunction
• Comorbidity management
• Integrated care approaches

Goal

Comprehensive patient management.

📸 Heart Failure Imaging & Biomarkers

Discussion of:

• Echocardiography
• Cardiac MRI
• Biomarker-guided care

Clinical Relevance

Diagnosis, prognosis, and monitoring.

🤝 Multidisciplinary Heart Failure Care

Review of:

• Team-based care models
• Nursing and pharmacy roles
• Transitional care strategies

Focus

Improving patient outcomes.

Educational Features

🎥 Expert-Led Presentations

Delivered by leading international heart failure specialists and researchers.

📚 State-of-the-Art Symposia

Focused discussions on emerging therapies and clinical innovations.

⚔️ Expert Debates

Evidence-based discussions on controversial and evolving topics.

🛠️ Hands-On Workshops

Practical education designed to enhance clinical skills.

📄 Scientific Abstracts & Research

Presentation of the latest heart failure investigations and clinical studies.

Who Should Attend

This program is ideal for:

Physicians

• Cardiologists
• Heart Failure Specialists
• Internists
• Cardiac Transplant Physicians
• Critical Care Physicians

Advanced Practice Providers

• Nurse Practitioners
• Physician Assistants

Allied Health Professionals

• Heart Failure Nurses
• Clinical Pharmacists
• Cardiac Rehabilitation Specialists

Trainees

• Cardiology Fellows
• Internal Medicine Residents
• Early Career Clinicians

Why This Course Is Valuable

✔ Comprehensive Heart Failure Education

✔ Guideline-Directed Medical Therapy Updates

✔ Advanced Heart Failure Management

✔ LVAD & Mechanical Support Strategies

✔ Heart Transplantation Updates

✔ Cardiogenic Shock Management

✔ Emerging Clinical Trial Data

✔ Multidisciplinary Care Approaches

✔ Expert Faculty & International Leaders

✔ Practical Clinical Applications

✔ Research & Innovation Highlights

✔ Evidence-Based Patient Care

Clinical & Educational Value

The HFSA 2019 Annual Scientific Meeting delivers a comprehensive update on modern heart failure care, combining cutting-edge scientific research with practical clinical guidance. Through multidisciplinary education and expert-led discussions, participants gain valuable knowledge on the diagnosis, treatment, and long-term management of heart failure patients across all stages of disease.

Topics/Speaker:

• 1. PM 1 – Excellence in Translational Science
• 2. SAT 1 – Mitral Regurgitation in Heart Failure 2019 Challenges and Opportunities
• 3. SAT 2 – Cardiovascular, Metabolic, and Renal Outcomes in Multi-Morbid Heart Failure Patients with Type 2 Diabetes
• 4. SAT 3 – Improving Outcomes in Your HF Patients with Evidence-Based Treatment of Hyperkalemia
• 5. PLENARY – Independence from Heart Failure Awareness, Empathy and Activism
• 6. SESSION 1 – Acute Cardiogenic Shock to Recovery STEMI, Myocarditis, and Acute Insults
• 7. SESSION 2 – Great Debates and Current Controversies Across the Atlantic
• 8. SESSION 3 – Ten Simple Tips How to Prevent HF
• 9. SESSION 4 – Prognosis and Treatments for Ambulatory Advanced HF
• 10. SESSION 5 – General Cardiology vs Community and Academic HF – Let’s Learn from Each Other
• 11. SESSION 6 – Ten Simple Tips Management of Complexities in Cardiogenic Shock
• 12. SESSION 7 – Rapid Fire Abstracts for Original Investigations
• 13. SESSION 8 – Challenges in Managing Adult Congenital Heart Disease PH, RV Failure, Arrhythmia
• 14. SESSION 9 – Change is Inevitable Impact of Nursing and Allied Health Amongst the Medical Circulatory Support World
• 15. SESSION 10 – FDA Special Session Focusing on Patient in Clinical Research and Drug Development
• 16. SAT 4 – Symptoms are the Tip of the Iceberg Navigating Management of Congestion in Heart Failure
• 17. SAT 5 – Team Based Approach to Combined Medical and Surgical Management of Advanced Heart Failure Optimal Use and Impact of Mechanical Circulatory Support
• 18. SESSION 11 – Ten Simple Tips Identifying the Ever-Elusive Volume Overload in the Clinic
• 19. SESSION 12 – 2019 Update on Clinical Trials for Emerging HF Drugs and Device Therapies
• 20. SESSION 13 – Defining RV Failure Pathophysiology and Clinical Perspectives
• 21. SESSION 14 – JNC Investigator Award Basic Science & Clinical
• 22. SESSION 15 – Nursing Investigator Award Research & Clinical1
• 23. SESSION 16 – Ten Simple Tips How to Best Implement Technologies to Assist in HF Care and Reduce Readmissions
• 24. SESSION 17 – Systemic Pathway Dysregulation in HFpEF How Mechanisms Enlighten Clinical Approaches
• 25. Session 18 – HF in End-Stage Kidney Disease A Multidisciplinary Approach to an Underestimated Problem1
• 26. SESSION 19 – Contemporary Dilemmas in LVAD Therapy
• 27. SESSION 20 – Fundamental skills for AHFTC Training
• 28. SESSION 22 – Systems of care in Cardiogenic Shock
• 29. 2018-2019 Top Ten Trials, News & Publication in HF
• 30. SESSION 26 – Payer Mandates for Formal Shared Decision-Making How do I Meet Coverage Decision Mandates
• 31. SESSION 23 – Translational Omics in Heart Failure Finally Getting Clinical
• 32. SESSION 25 – Lessons Learned 100 Years from HF Nurses
• 33. SESSION 27 – International Session Global Challenges and Best Practices in Acute HF
• 34. SESSION 28 – How to Diagnose and Manage Inflammatory Cardiomyopathies Myocarditis Foundation
• 35. Diet, Nutrition & Cardiac Function – From Beside to Bench & Back Again
• 36. SESSION 30 – Clinical Conundrums Pharmacotherapy for HFrEF Case-Based Debates
• 37. SESSION 31 – How to Engage Patient-Caregiver Dyads in Managing HF
• 38. SAT 6 – Reducing Cardiovascular and Renal Risk with SGLT2 Inhibitors Exploring Evidence
• 39. SAT 7 – Brave New World of ATTR Cardiac Amyloidosis Avoiding Pitfalls in Diagnosis and Treatment
• 40. SESSION 34 – Ten Simple Tips Cardiac Amyloidosis – No Longer an Academic Exercise, Now a Treatable Pandemic
• 41. Controversies in Acute Cardio-Renal Syndrome – Discussion & Debates on Fluid Wars
• 42. SESSION 35 – How to Manage Cardiovascular Complications during Pregnancy
• 43. Clinical Conundrums – Managing AFib & Device Therapies in HF – Case-Based Debates
• 44. SESSION 37 – Advocacy Committee The Multidimensional Challenge of Drug Pricing and Preapprovals
• 45. SESSION 39 – The Spectrum of Care for Patients with Genetic Cardiomyopathies
• 46. SESSION 38 – Late Breaking Clinical Trials
• 47. SESSION 40 – Ten Simple Tips Management of Patients with Diabetes and HF
• 48. SESSION 41 – Functional Mitral Regurgitation An Update on Treatment Strategies
• 49. SESSION 42 – Barriers to Implementation of New Therapies
• 50. SESSION 53 – Late Breaking Clinical Trials and Insights with Angiotensin Receptor Neprilysn Inhibitors
• 51. SESSION 43 – Ten Simple Tips How to Best Treat Volume Overload in Acute HF
• 52. SESSION 44 – New Insights in Cardio-Oncology
• 53. SESSION 45 – Understanding the Heart-Brain Connection New Insights in Cognitive Impairment and Sleep-Disordered Breathing
• 54. SESSION 46 – The New Heart Transplantation Allocation
• 55. SESSION 47 – Pharmacist-Driven Transition of Care and Optimization Clinics
• 56. SESSION 54 – HF Awareness in African Americans
• 57. SESSION 48 – HYDE PARK
• 58. SESSION 49 – Addressing the Recovered Ejection Fraction Is It Still Heart Failure
• 59. SESSION 50 – Ten Simple Tips Managing Patients Across the Spectrum of Pulmonary Hypertension
• 60. SESSION 51 – The Psychosocial Assessment of the Advanced HF Patient
• 61. SESSION 52 – Learning Health Systems, Real World Evidence and HF Hype or Reality